Quidel Solana HSV 1+2/VZV Test Kit

Quidel™ Solana HSV 1+2/VZV Assay is multiplex in vitro diagnostic test for detection and differentiation of Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), and Varicella-zoster virus (VZV) nucleic acids isolated and purified from cutaneous or mucocutaneous swab specimens.

Supplier:  Quidel M302

Catalog No. 23-043-114

Description

• For detection and differentiation of Herpes Simplex Virus (HSV) 1 and 2 and Varicella-zoster virus (VZV)
• HDA technology: Rapid method of nucleic acid amplification, does not require thermal cycler
• Lyophilized Master Mix reagent: Easy-to-use format, add processed sample to rehydrate
• CLIA complex: Moderate - Prescription Use Only
• Refrigerated storage: No freezer needed
• Eliminates need for dedicated molecular space and capital equipment, allowing for testing in smaller labs

Specifications

• Content And Storage: 2°C to 8°C (No ice or cooling block required)
• Sample Type: Cutaneous or mucocutaneous lesion samples obtained from symptomatic patients
• Type: Solana HSV 1+2/VZV Starter Kit
• Includes: Package insert, Dilution buffer, Lysis buffer, Reaction tubes; Lyophilized Master Mix reagent
• Test Time: ≈50 min.

• Clia Complexity: Moderate - Prescription Use Only
• Sensitivity: Cutaneous: 100% (HSV-1), 92.3% (HSV-2), 100% (VZV); Mucocutaneous: 100% (HSV-1), 99.1% (HSV-2), 100% (VZV); Non categorized: 100% (HSV-1), 100% (HSV-2), 100% (VZV)
• For Use With (Application): Diagnosis of Herpes Simplex Virus (HSV) 1 and 2 and Varicella-zoster virus (VZV)
• Specificity: Cutaneous: 98% (HSV-1), 94.4% (HSV-2), 96.5% (VZV); Mucocutaneous: 96.4% (HSV-1), 97.2% (HSV-2), 98.6% (VZV); Non categorized: 97.9% (HSV-1), 96.6% (HSV-2), 94.1% (VZV)

Safety and Handling

ShelfLife : Up to 12 Months from DOM